[1] Mandanda GA.Henderson ER,Johnson DA,et al.Orthopedic surgery options for the treatment of primary osteosarooma
[J].Cancer Centrol,2008,15(1):13-20.
[2] 黎承军,吴苏稼,施鑫.骨肉瘤新辅助化疗疗效评价方法研究进展
[J].医学研究生学报,2007,20(11):121l-1213.
[3] Ueda Y, Dockhorn-Dworniczak B, Blasius S, et al. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone
[J]. J Cancer Res Clin Oncol, 1993,119(3):172-178.
[4] Kaghad M,Bonnet H,Yang A,et a1.Monoallelically elpressed gen related to p53 at lq36,a region frequently deteted in neumblastoma and other human cancers
[J].Cell,1997,90(4):809-819.
[5] Lunghi P, Costanzo A, Mazzera L,et al. The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting
[J]. Clin Cancer Res,2009 ,15(21):6495-6502.
[6] Kommagani R, Whitlatch A, Leonard MK, Kadakia MP. p73 is essential for vitamin D-mediated osteoblastic differentiation
[J]. Cell Death Differ, 2010, 17(3):398-407.
[7] Lunghi P,Costanzo A, Mazzera L,et a1.The p53 family proteinp73 provides new insights into cancer chemosensitivity and targeting
[J].Clin Cancer Res,2009,15(21):6495-6502.
[8] Wang XH, O'Connor D, Brimmell M,et a1.The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
[J].Br J Cancer, 2009, 100(8): 1347-1357.
[9] Berns A. Cancer: The blind spot of p53
[J]. Nature, 2010, 468(7323):519-520.
[10] Kawahara M,Hori T,Chonabayashi K,et a1.Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
[J].Blood,2008,112(9):3856-3866.
[11] Foshay KM,Gallicano GI.Small RNAs,big potential:the role of MicroRNAs in stem cell function
[J].Curr Stem Cell Res Ther,2007,2(4):264-271.
[12] Micklem DR,Lorens JB.RNAi screening for therapeutic targets in human malignancies
[J].Curr Pharm Biotechnol,2007,8(6):337-343.
[13] Ying SY,Chang DC,Lin SL.The microRNA(miRNA):overview of the RNA genes that modulate gene function
[J].Mol Biotechnol,2008,38(3):257-268.